Management of craniopharyngiomas

Journal of Endocrinological Investigation

Volumn 37, Issue 3, 2014, Pages 219-228

  Karavitaki, N ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Craniopharyngiomas; Hypopituitarism; Hypothalamus; Pituitary

Indexed keywords

ALPHA INTERFERON; BETA CATENIN; BLEOMYCIN; CORTICOTROPIN; FOLLITROPIN; GADOLINIUM; GROWTH HORMONE; KERATIN; LUTEINIZING HORMONE; MEMBRANE LIPID; THYROTROPIN; VASOPRESSIN;

ARACHNOID CYST; BASEMENT MEMBRANE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CLINICAL FEATURE; COMPUTER ASSISTED RADIOTHERAPY; CRANIOPHARYNGIOMA; CYTOSKELETON; DIFFERENTIAL DIAGNOSIS; EPIDERMOID CYST; EPITHELIUM; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GERM CELL TUMOR; GLIOMA; GROWTH DISORDER; HALF LIFE TIME; HAMARTOMA; HEADACHE; HUMAN; HYDROCEPHALUS; HYPOGONADISM; HYPOPHYSIS ADENOMA; HYPOPHYSIS FUNCTION; INTERMETHOD COMPARISON; INTRACYSTIC IRRADIATION; IRRADIATION; LANGERHANS CELL HISTIOCYTOSIS; MAXIMUM TOLERATED DOSE; MENINGIOMA; MINIMALLY INVASIVE PROCEDURE; MORBIDITY; MORTALITY; NAUSEA; NEUROSURGERY; ODONTOGENIC CYST; OMMAYA RESERVOIR; OUTCOME ASSESSMENT; PATHOGENESIS; PINEAL BODY; PONS ANGLE; POSTERIOR FOSSA; PREVALENCE; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION INJURY; RATHKE CLEFT CYST; RECURRENCE RISK; REVIEW; SARCOIDOSIS; SKULL RADIOGRAPHY; SQUAMOUS EPITHELIUM; STELLATE CELL; STEREOTACTIC RADIOSURGERY; SURGICAL APPROACH; SYSTEMIC CHEMOTHERAPY; TEMPORAL LOBE; TERATOMA; TUBERCULOSIS; TUMOR RECURRENCE; VISUAL DISORDER; VOMITING; WNT SIGNALING PATHWAY; DISEASE MANAGEMENT; PITUITARY NEOPLASMS;

CRANIOPHARYNGIOMA; DISEASE MANAGEMENT; HUMANS; PITUITARY NEOPLASMS; PROGNOSIS;

EID: 84900532990     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-013-0050-9     Document Type: Review

References (76)

1. Karavitaki N, Cudlip S, Adams CB, Wass JA (2006) Craniopharyngiomas. Endocr Rev 2006(27):371-397
2. Larkin SJ, Ansorge O (2013) Pathology and pathogenesis of craniopharyngiomas. Pituitary 16(1):9-17
3. Crotty TB, Scheithauer BW, Young WF Jr et al (1997) Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg 83:206-214
4. Petito CK, De Girolami U, Earle KM (1976) Craniopharyngiomas: a clinical and pathological review. Cancer 37:1944-1952
5. Weiner HL, Wisoff JH, Rosenberg ME et al (1994) Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 35:1001-1011
6. Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M (1999) Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90:237-250
7. Karavitaki N, Brufani C, Warner JT et al (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol 62:397-409
8. Van Effentere R, Boch AL (2002) Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg 97(1):3-11
9. Sartoretti-Schefer S, Wichmann W, Aguzzi A, Valavanis A (1997) MRI differentiation of adamantinous and squamous-papillary craniopharyngiomas. Am J Neuroradiol 18(1):77-87
10. Byrne JV (2002) Imaging of the pituitary. In: Wass JAH, Shalet SM (eds) Oxford textbook of endocrinology and diabetes, 1st edn. Oxford University Press, Oxford, pp 136-145
11. Komotar RJ, Starke RM (2012) Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of craniopharyngiomas. World Neurosurg 77(2):329-341
12. Buchfelder M, Schlaffer SM, Lin F, Kleindienst A (2013) Surgery for craniopharyngioma. Pituitary 16:18-25
13. Elliott RE, Jane JA Jr, Wisoff JH (2011) Surgical management of craniopharyngiomas in children: meta-analysis and comparison of transcranial and transsphenoidal approaches. Neurosurgery 69(3):630-643
14. Carpenter RC, Chamberlin GW, Frazier CH (1937) The treatment of hypophyseal stalk tumours by evacuation and irradiation. Am J Roent 38:162-167
15. Kramer S, Mckissock W, Concanon JP (1961) Craniopharyngiomas: treatment by combined surgery and radiation therapy. J Neurosurg 18:217-226
16. Costine LS, Randall SH, Rubin P, McDonald J (1989) Craniopharyngiomas: fluctuation in cyst size following surgery and radiation therapy. Neurosurgery 24:53-59
17. Rajan B, Ashley S, Thomas DGT et al (1997) Craniopharyngioma: improving outcome by early recognition and treatment of acute complications. Int J Radiat Oncol Biol Phys 37:517-521
18. Shi Z, Esiashvili N, Janss AJ et al (2012) Transient enlargement of craniopharyngioma after radiation therapy: pattern of magnetic resonance imaging response following radiation. J Neurooncol 109(2):349-355
19. Minniti G, Saran F, Traish D et al (2007) Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother Oncol 82:90-95
20. Combs SE, Thilmann C, Huber PE et al (2007) Achievement of long term control in patients with craniopharyngiomas using high precision stereotactic radiotherapy. Cancer 109:2308-2314
21. Rajan B, Ashley S, Gorman C et al (1993) Craniopharyngioma - long-term results following limited surgery and radiotherapy. Radiother Oncol 26:1-10
22. Jose CC, Rajan B, Ashley S, Marsh H, Brada M (1992) Radiotherapy for the treatment of recurrent craniopharyngioma. Clin Oncol 4:287-289
23. Gutin DH, Klemme WM, Lagger RI, Mackay AR, Pitts LH, Hojobuchi Y (1980) Management of unresectable cystic craniopharyngioma by aspiration through an Ommaya reservoir drainage system. J Neurosurg 52:36-40
24. Spaziante R, Irace C, De Divitiis E (1993) Brachytherapy of cystic craniopharyngiomas. J Neurosurg 79:966-967
25. Pollock BE, Lunsford LD, Kondziolka D, Levine G, Flickinger JC (1995) Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long-term results. Int J Radiat Oncol Biol Phys 33:437-446
26. Voges J, Sturm V, Lehrke R, Treuer H, Gauss C, Berthold F (1997) Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal b-emitting radioactive sources. Neurosurgery 40:263-270
27. Van den Berge JH, Blaauw G, Breeman WAP, Rahmy A, Wijngaarde R (1992) Intracavitary brachytherapy of cystic craniopharyngiomas. J Neurosurg 77:545-550
28. Hasegawa T, Kondzilka D, Hadjipanayis CG, Lunsford LD (2004) Management of cystic craniopharyngiomas with phos-phorus- 32 intracavitary irradiation. Neurosurgery 54:813-822
29. Julow JV (2013) Intracystic irradiation for craniopharyngiomas. Pituitary 16(1):34-35
30. Kickingereder P, Maarouf M, El Majdoub F et al (2012) Intracavitary brachytherapy using stereotactically applied phosphorus- 32 colloid for treatment of cystic craniopharyngiomas in 53 patients. J Neurooncol 109(2):365-367
31. Takahashi H, Nakazawa S, Shimura T (1985) Evaluation of postoperative injection of bleomycin for craniopharyngioma in children. J Neurosurg 62:120-127
32. Hader WJ, Steinbok P, Hukin J, Fryer C (2000) Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children. Pediatr Neurosurg 33:211-218
33. Broggi G, Franzini A, Cajola L, Pluchino F (1994) Cell kinetic investigations in craniopharyngioma: preliminary results and considerations. Pediatr Neurosurg 21:21-23
34. Leber KA, Bergloeff J, Pendl G (1998) Dose response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 88:43-50
35. Xu Z, Yen CP, Schlesinger D et al (2011) Outcomes of gamma knife surgery for craniopharyngioma. J Neurooncol 104(1):305-313
36. Niranjan A, Kano H, Mathieu D et al (2010) Radiosurgery for craniopharyngioma. Int J Radiat Oncol Biol Phys 78(1):64-71
37. Kobayashi T, Kida Y, Mori Y et al (2005) Long-term results of gamma knife surgery for treatment of craniopharyngioma in 98 consecutive cases. J Neurosurg Pediatr 103(suppl):482-488
38. Aggarwal A, Fersht N, Brada M (2013) Radiotherapy for craniopharyngioma. Pituitary 16(1):26-33
39. Bremmer AM, Nguyen TQ, Balsys R (1984) Therapeutic benefits of combination chemotherapy with vincristine, BCNU, and procarbazine on recurrent cystic craniopharyngioma. A case report. J Neurooncol 2:47-51
40. Lippens RJ, Rotteveel JJ, Otten BJ, Merx H (1998) Chemotherapy with adriamycin (doxorubicin) and CCNU (lomustine) in four children with recurrent craniopharyngioma. Eur J Paediatr Neurol 2:263-268
41. Yeung JT, Pollack IF, Panigraphy et al (2012) Pegylated interferon-a-2b for children with recurrent craniopharyngioma. J Neurosurg Pediatr 10(6):498-503
42. Jakacki RI, Cohen BH, Jamison C et al (2000) Phase II evaluation of interferon-α-2a for progressive recurrent craniopharyngiomas. J Neurosurg 92:250-260
43. Cohen M, Bartels U, Branson H, Kulkarni AV, Hamilton J (2013) Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011. Neuro Oncol 15(6):767-774
44. Toledano Y, Lubetsky A, Shimon I (2007) Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axis. J Endocrinol Invest 30:268-273
45. De Vile CJ, Grant DB, Hayward RD, Stanhope R (1996) Growth and endocrine sequelae of craniopharyngioma. Arch Dis Child 75:108-114
46. Schoenle EJ, Zapf J, Prader A, Torresani T, Werder EA, Zachemann M (1995) Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma. J Clin Endocrinol Metab 80:374-378
47. Sklar CA (1994) Craniopharyngioma: endocrine sequelae of treatment. Pediatr Neurosurg 21:120-123
48. Kendall-Taylor P, Jönsson PJ, Abs R et al (2005) The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol 152:557-567
49. Price DA, Wilton P, Jonsson P et al (1998) Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996. Horm Res 49:91-97
50. Geffner M, Lundberg M, Koltowska-Haggstrom M et al (2004) Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J Clin Endocrinol Metab 89:5435-5440
51. Verhelst J, Kendall-Taylor P, Erfurth EM et al (2005) Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database). J Clin Endocrinol Metab 90:4636-4643
52. Ulfarsson E, Karstrom A, Yin S et al (2005) Expression and growth dependency of the insulin-like growth factor I receptor in craniopharyngioma cells: a novel therapeutic approach. Clin Cancer Res 11:4674-4680
53. Karavitaki N (2007) Hypopituitarism oddities: craniopharyngiomas. Horm Res 68(Suppl 5):151-153
54. Karavitaki N, Warner JT, Marland A et al (2006) GH replacement does not increase the risk of recurrence in patients with craniopharyngiomas. Clin Endocrinol 64:556-560
55. Daousi C, Dunn AJ, Foy PM, MacFarlane IA, Pinkney JH (2005) Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage. JAMA 118:45-50
56. Stripp DC, Maity A, Janss AJ et al (2004) Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys 28:714-720
57. Pereira AM, Scmid EM, Schutte PJ et al (2005) High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngiomas. Clin Endocrinol 62:197-204
58. De Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BGR, Stanhope R (1996) Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab 81:2734-2737
59. Roth C, Wilken B, Hanefeld F, Schroter F, Leonhardt U (1998) Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 138:89-91
60. Pinkney J, Wilding J, Williams G, MacFarlane I (2002) Hypothalamic obesity in humans: what do we know and what can be done? Obes Rev 3:27-34
61. Harz KJ, Muller HL, Waldeck E, Pudel V, Roth C (2003) Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab 88:5227-5231
62. Holmer H, Pozarek G, Wirfält E et al (2010) Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma. J Clin Endocrinol Metab 95:5395-5402
63. Piguel P, Abraham P, Bouchours-Nouet N et al (2012) Impaired aerobic exercise adaptation in children and adolescents with craniopharyngioma is associated with hypothalamic involvement. Eur J Endocrinol 166:215-222
64. Goldstone AP, Patterson M, Kalingag N et al (2005) Fasting and post-prandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to PYY deficiency or seen in hypothalamic obesity due to craniopharyngioma. J Clin Endocrinol Metab 90:2681-2690
65. Elowe-Gruau E, Beltrand J, Brauner R et al (2013) Childhood craniopharyngioma; hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metab 98(6):2376-2382
66. Bretault M, Boillot A, Muzzard L et al (2013) Clinical review: bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis. J Clin Endocrinol Metab 98(6):2239-2246
67. Weismann D, Pelka T, Bender G et al (2013) Bariatric surgery for morbid obesity in craniopharyngioma. Clin Endocrinol 78:385-390
68. Mason PW, Krawiecki N, Meacham LR (2002) The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 156:887-892
69. Hamilton JK, Conwell LS, Syme C, Ahmet A, Jeffery A, Daneman D (2011) Hypothalamic obesity following craniopharyngioma surgery: results of a pilot trial of combined diazoxide and metformin therapy. Int J Pediatr Endocrinol 2011:417949
70. Lustig RH, Hinds PS, Ringwald-Smith K et al (2003) Octreotide therapy of pediatric hypothalamic obesity: a doubleblind, placebo-controlled trial. J Clin Endocrinol Metab 88:2586-2592
71. Zoicas F, Droste M, Mayr B, Buchfelder M, Schofl C (2013) GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases. Eur J Endocrinol 168(5):699-706
72. Duff JM, Meyer FB, Ilstrup DM, Laws ERJr, Scleck CD, Scheithauer BW (2000) Long-term outcomes for surgically resected craniopharyngiomas. Neurosurgery 46(2):291-305
73. Gautier A, Godbout A, Grosheny C et al (2012) Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients. J Clin Endocrinol Metab 97(4):1258-1267
74. Di Pinto M, Conklin HM, Merchant TE (2012) Learning and memory following conformal radiation therapy for paediatric craniopharyngioma and low-grade glioma. Int J Radiat Oncol Biol Phys 84(3):363-369
75. Varlotto JM, Flickinger JC, Kondziolka D, Lunsford LD, Deutch M (2002) External beam irradiation of craniopharyngiomas: long-term analysis of tumour control and morbidity. Int J Radiat Oncol Biol Phys 54:492-499
76. Erfurth EM, Holmer H, Fjalldal SB (2013) Mortality and morbidity in adult craniopharyngioma. Pituitary 16(1):46-55